Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
Evan Rosenbaum, Cristina R. Antonescu, Shaleigh Smith, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e004149-e004149
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates
Candace L. Haddox, Michael J. Nathenson, Emanuele Mazzola, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 7, pp. 1281-1292
Open Access | Times Cited: 15
Multiomics characterization of breast angiosarcoma from an Asian cohort reveals enrichment for angiogenesis signaling pathway and tumor-infiltrating macrophages
Tun Kiat Ko, Zexi Guo, Bavani Kannan, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma
Jui Wan Loh, Jing Yi Lee, Abner Herbert Lim, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 17
Cutaneous angiosarcoma: A review of current evidence for treatment with checkpoint inhibitors
Lucy Guan, Marisa Palmeri, Roman Groisberg
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 14
Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications
Siyu Wang, Hua Wang, Chenbei Li, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 5
Exploring anti-tumor potential of food and medicine homology substances: An in-silico evaluation of Citri Grandis Exocarpium against gallbladder cancer
Jia-Tong Li, Ao Gu, Nannan Tang, et al.
Food & medicine homology. (2025)
Closed Access
Angiosarcoma: Role of Immunotherapy
Tom Wei‐Wu Chen
Current Treatment Options in Oncology (2025)
Closed Access
Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterization
Daniela A. Ferraro, Bettina Bisig, David C. Rotzinger, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Mapping the potential for anti-PD-1 therapy in advanced rare skin carcinomas
Clio Dessinioti, Alexander J. Stratigos
European Journal of Cancer (2025), pp. 115403-115403
Closed Access
Primary pulmonary angiosarcoma mimicking acute interstitial pneumonia – a diagnostic challenge: A case report
Magdalena Chrabańska
Medicine (2025) Vol. 104, Iss. 17, pp. e42106-e42106
Open Access
Younger Age Is Associated with Favorable Outcomes in Adult Dogs with Hemangiosarcoma Receiving Adjuvant Doxorubicin Chemotherapy: Results from the PRO-DOX Study
Antonella Borgatti, Brian D. Husbands, Aaron L. Sarver, et al.
Research Square (Research Square) (2025)
Closed Access
Cutaneous Angiosarcoma of the Head and Neck—A Retrospective Analysis of 47 Patients
Neeraj Ramakrishnan, Ryan Mokhtari, Gregory W. Charville, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3841-3841
Open Access | Times Cited: 15
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group
Elena Palassini, Giacomo Giulio Baldi, S. Sulfaro, et al.
Cancer Treatment Reviews (2024) Vol. 126, pp. 102722-102722
Open Access | Times Cited: 3
NK cell based immunotherapy against oral squamous cell carcinoma
Ying Zhang, Jianming Xie, Haoran Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups
Stefan G. van Ravensteijn, Yvonne M.H. Versleijen‐Jonkers, Melissa H.S. Hillebrandt-Roeffen, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5938-5938
Open Access | Times Cited: 14
Primary vascular tumors of bone: A comprehensive literature review on classification, diagnosis and treatment
Ilaria Tortorelli, Elena Bellan, Benedetta Chiusole, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 195, pp. 104268-104268
Open Access | Times Cited: 2
Molecular and immune pathobiology of human angiosarcoma
Ryan Mao Heng Lim, Jing Yi Lee, Bavani Kannan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189159-189159
Closed Access | Times Cited: 2
Primary pulmonary angiosarcoma mimicking diffuse pulmonary hemorrhage: A case report
Yong Lin, Han Yu, Changying Wang, et al.
Oncology Letters (2023) Vol. 25, Iss. 5
Open Access | Times Cited: 4
Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma
Qi Wang, Zhuoran Tang, Chunyu Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Tumor Immune Microenvironment and Its Clinicopathological and Prognostic Associations in Canine Splenic Hemangiosarcoma
Chiara Brachelente, Filippo Torrigiani, Ilaria Porcellato, et al.
Animals (2024) Vol. 14, Iss. 8, pp. 1224-1224
Open Access | Times Cited: 1
Clinical perspectives and outcomes of the giant breast phyllodes tumor and sarcoma: a real-world retrospective study
Naiquan Liu, Ye Kang, Ningxin Qu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Angiosarcomas of the head and neck: Impact of large data analysis on clinical management
Volkert B. Wreesmann, Karin P. Q. Oomen, Peter A. Brennan
Journal of Oral Pathology and Medicine (2022) Vol. 51, Iss. 10, pp. 904-910
Closed Access | Times Cited: 5
Comprehensive analysis of immune ferroptosis gene in renal clear cell carcinoma: prognosis and influence of tumor microenvironment.
Linhui Yang, Lizhen Xu, Zhijian Huang, et al.
PubMed (2022) Vol. 14, Iss. 9, pp. 5982-6010
Closed Access | Times Cited: 4
Primary Breast Angiosarcoma: Comparative Transcriptome Analysis
Andrés Rincón‐Riveros, Jairo de la Peña, Wilson Rubiano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16032-16032
Open Access | Times Cited: 3
The challenge of running trials in advanced angiosarcoma: A systematic review of the literature from EORTC/STBSG to guide the development of angiosarcoma-specific trials
Armelle Dufresne, Lars H. Lindner, Jana K. Striefler, et al.
European Journal of Cancer (2024) Vol. 207, pp. 114188-114188
Closed Access
Page 1 - Next Page

Scroll to top